⌘K

Login Start Free

Home/Filings/4/0001628280-22-030946

4//SEC Filing

Erlander Mark 4

Accession 0001628280-22-030946

CIK 0001213037other

View on SEC.gov Company Profile

Filed

Nov 28, 7:00 PM ET

Accepted

Nov 29, 4:11 PM ET

Size

4.7 KB

Accession

0001628280-22-030946

Insider Transaction Report

Form 4

Period: 2022-11-25

Cardiff Oncology, Inc.CRDF

DirectorChief Executive Officer

Transactions

Purchase
Common Stock
2022-11-25$1.43/sh+10,000$14,300→ 24,481 total

Documents

1 file

4
wf-form4_166975625707899.xmlPrimary
FORM 4

Issuer

Cardiff Oncology, Inc.

CIK 0001213037

Entity typeother

Related Parties

1

filerCIK 0001651537

Filing Metadata

Form type: 4
Filed: Nov 28, 7:00 PM ET
Accepted: Nov 29, 4:11 PM ET
Size: 4.7 KB

View on SEC.gov